Find your next paid study

National Cancer Institute (NCI)NCT06995872

~$150 – $2,700

Actual pay is set by the research site.

Phase 2

A Double Blind, Placebo-controlled Trial of LAM-001 for Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)

A Phase 2, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAM-001 (Inhaled Sirolimus) in Adults with Sar…

Sarcoidosis Associated Pulmonary Hypertension

IRulya Therapeutics Inc.NCT07886554

~$75 – $2,800

Actual pay is set by the research site.

Emotional RegulationAlcohol Drinking in CollegeEmotional Eating+1 more

REACT Biomarker and Extended-Measures Study: Hair Steroids, Psychosocial Moderators, and Momentary Reactive Behavior in College Students

This study looks at the moments when college students feel a strong emotional swing, and how those moments relate to reacting online when upset, drinking alcoh…

University of FloridaNCT07782398

Actual pay is set by the research site.

Type 2 Diabetes Mellitus (T2DM)Diabetes Distress

ARISE: Achieving Routine Intervention and Screening for Emotional Health: Randomized Controlled Trial

The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).

University of ChicagoNCT06887049

Actual pay is set by the research site.

Phase 1

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

This is a Phase 1, open-label, dose-escalation study of CBX-663 in participants with R/R AML, MDS or CMML (Cohort A), advanced solid tumors (Cohort B), or recu…

Advanced Solid TumorsRecurrent or Progressive GlioblastomaRelapse or Refractory Myeloid Malignancies

Crossbow Therapeutics, Inc.NCT07779798

~$150 – $4,200

Actual pay is set by the research site.

Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class III

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure (BENEFIT-HF)

The purpose of BENEFIT-HF is to demonstrate the safety and effectiveness of Baroreflex Activation Therapy (BAT) with the Barostim System in participants with h…

~$10 – $1,050

Actual pay is set by the research site.

CVRx, Inc.NCT07232030

Phase 2

A Proof-of-Concept Open-Label Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of CSTI-500 in Participants With Prader-Willi Syndrome

This is a proof-of-concept, open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of CSTI-500 in participants …

Prader-Willi Syndrome

ConSynance TherapeuticsNCT07348601

~$75 – $2,800

Actual pay is set by the research site.

Evaluation of a Point-of-Care, AI-Powered Spectroscopy Device for Triage of Suspicious Vulvar Lesions: A Pilot Study

This purpose of this study is to assess the feasibility of using the DermaSensor™ device on vulvar skin.

Vulvar Intraepithelial Neoplasia, HPV-IndependentVulvar Squamous Cell CarcinomaVulvar Squamous Intraepithelial Lesion, HPV-Associated

Actual pay is set by the research site.

Mayo ClinicNCT07886203

Phase 1

A Multicenter, Open Label, Non-randomized First-in-human Phase 1 Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of BAY 3547926 Alone, and in Combination, in Participants With Advanced Hepatocellular Carcinoma (HCC)

In this study, researchers want to learn about the safety of a new drug, BAY 3547926, and how well the drug works in people with a type of liver cancer called …

Hepatocellular Carcinoma

~$150 – $4,500

Actual pay is set by the research site.

BayerNCT06764316

Obesity, MorbidMetabolic SyndromeNASH - Nonalcoholic Steatohepatitis

Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach

Variable outcomes after weight loss surgery are likely attributable to complex, poorly understood mechanisms. Due to the significant impact that morbid obesity…

University of Missouri-ColumbiaNCT04841057

Actual pay is set by the research site.

Phase 2

A Phase 2, Open-label, Fixed-dose Study to Assess the Efficacy of Sodium Phenylbutyrate (ACER-001) in Treating Pediatric and Adult Patients With Medium Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Resulting From the Prevalent ACADM c.985 A>G (K304E) Mutation

This is a medical research study to test a medication in patients 4 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency…

Medium-chain Acyl-CoA Dehydrogenase Deficiency

Jerry Vockley, MD, PhDNCT06773026

~$75 – $3,000

Actual pay is set by the research site.

Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Background: Researchers seek ways to study people s medical problems in order to teach and further general knowledge. The ability to assess and treat people w…

Wide Spectrum of DiseasesHematologic Diseases